Jakub Simon
Overview
Explore the profile of Jakub Simon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
175
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valayer S, Alexandre M, Prague M, Beavogui A, Doumbia S, Kieh M, et al.
Emerg Microbes Infect
. 2024 Nov;
14(1).
PMID: 39559990
rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo are WHO-prequalified vaccination regimens against Ebola virus disease (EVD). Challenges associated with measuring long-term clinical protection warrant the evaluation of immune response kinetics after vaccination. Data...
2.
Kieh M, Richert L, Beavogui A, Grund B, Leigh B, DOrtenzio E, et al.
N Engl J Med
. 2022 Dec;
387(26):2411-2424.
PMID: 36516078
Background: Questions remain concerning the rapidity of immune responses and the durability and safety of vaccines used to prevent Zaire Ebola virus disease. Methods: We conducted two randomized, placebo-controlled trials...
3.
Robbins J, Tait D, Huang Q, Dubey S, Crumley T, Cote J, et al.
EBioMedicine
. 2022 Jul;
82:104138.
PMID: 35809371
Background: Vaccines against COVID-19 are needed to overcome challenges associated with mitigating the global pandemic. We report the safety and immunogenicity of V590, a live recombinant vesicular stomatitis virus-based COVID-19...
4.
Mahon B, Simon J, Widdowson M, Samai M, Rogier E, Legardy-Williams J, et al.
J Infect Dis
. 2021 May;
224(11):1907-1915.
PMID: 34013349
Background: The effect of malaria infection on the immunogenicity of the recombinant vesicular stomatitis virus-Zaire Ebola virus envelope glycoprotein (GP) vaccine (rVSVΔG-ZEBOV-GP) (ERVEBO) is unknown. Methods: The Sierra Leone Trial...
5.
Grant-Klein R, Antonello J, Nichols R, Dubey S, Simon J
Am J Trop Med Hyg
. 2019 Jun;
101(1):207-213.
PMID: 31162004
rVSVΔG-ZEBOV-GP vaccine is a live recombinant (r) vesicular stomatitis virus (VSV), where the VSV G protein is replaced with the Zaire Ebola virus (ZEBOV) glycoprotein (GP). For vaccine immunogenicity testing,...
6.
Coller B, Blue J, Das R, Dubey S, Finelli L, Gupta S, et al.
Vaccine
. 2017 Jun;
35(35 Pt A):4465-4469.
PMID: 28647166
The 2014-2016 Ebola outbreak caused over 28,000 cases and 11,000 deaths. Merck & Co. Inc., Kenilworth, NJ USA and NewLink Genetics are working with private and public partners to develop...
7.
Boisen N, Scheutz F, Rasko D, Redman J, Persson S, Simon J, et al.
J Infect Dis
. 2011 Dec;
205(3):431-44.
PMID: 22184729
Background: Enteroaggregative Escherichia coli (EAEC) is a cause of epidemic and sporadic diarrhea, yet its role as an enteric pathogen is not fully understood. Methods: We characterized 121 EAEC strains...
8.
Simon J, Kotloff K
Curr Opin Gastroenterol
. 2009 Dec;
26(1):12-6.
PMID: 19952742
Purpose Of Review: To summarize recent advances that contribute to the development of new vaccines against gastrointestinal infections. Recent Findings: The main themes of this review include epidemiology assessing disease...